Trials / Unknown
UnknownNCT04268108
L-TIL in Patients With Malignancy Resistance to Anti-PD-1 Therapy
Clinical Study of Liquid Tumor Infiltrating Lymphocytes in Patients With Advanced Malignancies Resistance to Anti-PD-1 Therapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Henan Cancer Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Safety and effectiveness of liquid tumor infiltrating lymphocytes in patients with advanced malignant tumors who have failed to anti-PD-1 therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | liquid tumor infiltrating lymphocytes | Isolatation and amplification PD-1+ cells from peripheral blood lymphocytes under GMP conditions for clinical use. |
Timeline
- Start date
- 2020-04-02
- Primary completion
- 2022-02-19
- Completion
- 2022-06-19
- First posted
- 2020-02-13
- Last updated
- 2020-06-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04268108. Inclusion in this directory is not an endorsement.